000 01446 a2200325 4500
005 20250515233937.0
264 0 _c20110202
008 201102s 0 0 eng d
022 _a1557-3265
024 7 _a10.1158/1078-0432.CCR-10-1664
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKashkar, Hamid
245 0 0 _aX-linked inhibitor of apoptosis: a chemoresistance factor or a hollow promise.
_h[electronic resource]
260 _bClinical cancer research : an official journal of the American Association for Cancer Research
_cSep 2010
300 _a4496-502 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCell Transformation, Neoplastic
_xgenetics
650 0 4 _aDrug Resistance, Neoplasm
_xgenetics
650 0 4 _aHumans
650 0 4 _aModels, Biological
650 0 4 _aMolecular Targeted Therapy
_xmethods
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aTherapies, Investigational
_xmethods
650 0 4 _aTranslational Research, Biomedical
_xmethods
650 0 4 _aX-Linked Inhibitor of Apoptosis Protein
_xantagonists & inhibitors
773 0 _tClinical cancer research : an official journal of the American Association for Cancer Research
_gvol. 16
_gno. 18
_gp. 4496-502
856 4 0 _uhttps://doi.org/10.1158/1078-0432.CCR-10-1664
_zAvailable from publisher's website
999 _c20021620
_d20021620